Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey

被引:10
|
作者
Magnani, Clement [1 ]
Ben Smith, Allan [2 ,3 ]
Rey, Dominique [4 ]
Sarradon-Eck, Aline [4 ,5 ]
Preau, Marie [6 ,7 ]
Bendiane, Marc-Karim [4 ]
Bouhnik, Anne-Deborah [4 ]
Mancini, Julien [8 ]
机构
[1] Aix Marseille Univ, Marseille, France
[2] Ingham Inst Appl Med Res, Sydney, NSW, Australia
[3] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia
[4] Aix Marseille Univ, Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,ISSPAM, SESSTIM,Sci Econ & Sociales Sante & Traitement In, Marseille, France
[5] Inst Paoli Calmettes, SESSTIM, Marseille, France
[6] Unite UMR 1296 Radiat Def Sante Environm, Lyon, France
[7] Univ Lumiere Lyon 2, Inst Psychol, Bron, France
[8] Aix Marseille Univ, Hop Timone,BioSTIC,Biostat & Technol Informat & C, AP HM,ISSPAM,Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,SESSTIM,Sci Econ & Sociales Sante & Tr, Marseille, France
关键词
Cancer survivors; Fear of recurrence; General practitioner; Breast; Thyroid; Melanoma; QUALITY-OF-LIFE; FOLLOW-UP CARE; BREAST-CANCER; HEALTH LITERACY; SURVIVORS; ASSOCIATION; PROGRESSION; PREVALENCE; VALIDATION; DEPRESSION;
D O I
10.1007/s11764-022-01193-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Fear of cancer recurrence (FCR) is frequent in survivors, but less is known about FCR in long-term survivors with very low risk of relapse. Our aim was to estimate the prevalence and clinical and socio-behavioural factors associated with FCR in young women 5 years after diagnosis of a good-prognosis cancer. Methods Using data from the VICAN-5 survey, conducted in 2015-2016 amongst a national representative French sample of cancer survivors, we included women with non-metastatic melanoma, breast, or thyroid cancer, aged 55 years or under at diagnosis, who experienced no disease progression in the 5 years post-diagnosis. Multinomial logistic regression was used to identify factors associated with FCR, characterised using a three-level indicator: no, mild, and moderate/severe FCR. Results Amongst the 1153 women included, mean age was 44 years at diagnosis, and 81.8% had breast cancer, 12.5% thyroid cancer, and 5.8% melanoma. Five years after diagnosis, 35.4% reported no FCR, 46.0% mild FCR, and 18.6% moderate/severe FCR. Women with thyroid cancer were less likely to suffer from mild or moderate/severe FCR, while cancer-related treatment sequelae, fatigue, and anxiety were more likely. Limited health literacy was associated with mild FCR. Women who reported only occasionally consulting a general practitioner (GP) for the management of their cancer had a higher probability of FCR. Conclusion Moderate/severe FCR affected nearly 20% of young female long-term survivors diagnosed with a good-prognosis cancer, particularly those reporting cancer-related sequelae, suffering from fatigue or anxiety, with breast cancer or melanoma (versus thyroid cancer), and consulting a GP only occasionally for cancer management. I mplications for Cancer Survivors Given the recognised impact of FCR on quality of life, it is essential to detect it as early as possible, and to implement targeted interventions in routine care.
引用
收藏
页码:1359 / 1370
页数:12
相关论文
共 50 条
  • [1] Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey
    Clément Magnani
    Allan Ben Smith
    Dominique Rey
    Aline Sarradon-Eck
    Marie Préau
    Marc-Karim Bendiane
    Anne-Déborah Bouhnik
    Julien Mancini
    Journal of Cancer Survivorship, 2023, 17 : 1359 - 1370
  • [2] Returning to work by thyroid cancer survivors 5 years after diagnosis: The VICAN Survey
    Creff, Gwenaelle
    Jegoux, Franck
    Bendiane, Marc-Karim
    Babin, Emmanuel
    Licaj, Idlir
    ORAL ONCOLOGY, 2021, 118
  • [3] Returning to work by thyroid cancer survivors 5 years after diagnosis: the VICAN survey
    G. Creff
    F. Jegoux
    M.-K. Bendiane
    E. Babin
    I. Licaj
    Journal of Cancer Survivorship, 2022, 16 : 801 - 811
  • [4] Returning to work by thyroid cancer survivors 5 years after diagnosis: the VICAN survey
    Creff, G.
    Jegoux, F.
    Bendiane, M-K
    Babin, E.
    Licaj, I
    JOURNAL OF CANCER SURVIVORSHIP, 2022, 16 (04) : 801 - 811
  • [5] Second cancer screening among 5-years women cancer survivors (French National Survey VICAN5)
    Bendiane, M. K.
    Bouhnik, A-D.
    Monet, A.
    Chatta, I.
    Rey, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Sexual health 2 years after diagnosis of cancer - National survey VICAN
    Ben Charif, A.
    Bouhnik, A. -D.
    Rey, D.
    Preau, M.
    Courbiere, B.
    Mancini, J.
    BULLETIN DU CANCER, 2015, 102 (06) : S128 - S129
  • [7] Deterioration of sexual health of cancer survivors 5 years after diagnosis - French national cohort VICAN
    Seguin, L.
    Touzani, R.
    Bouhnik, A-D.
    Ben CharifF, A.
    Marino, P.
    Bendiane, M. K.
    Goncalves, A.
    Mescam, G. Gravis
    Mancini, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1070 - S1070
  • [8] Social and sexual health of thyroid cancer survivors 2 and 5 years after diagnosis: the VICAN survey
    Gwenaelle Creff
    Franck Jegoux
    Marc Karim Bendiane
    Emmanuel Babin
    Idlir Licaj
    Supportive Care in Cancer, 2022, 30 : 2777 - 2785
  • [9] Social and sexual health of thyroid cancer survivors 2 and 5 years after diagnosis: the VICAN survey
    Creff, Gwenaelle
    Jegoux, Franck
    Bendiane, Marc Karim
    Babin, Emmanuel
    Licaj, Idlir
    SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 2777 - 2785
  • [10] The impact of endocrine therapy and chemotherapy on quality of life 5 years after a breast cancer diagnosis: VICAN5 survey
    Memoli, V.
    Rey, D.
    Lauzier, S.
    Mancini, J.
    Bouhnik, A-D.
    ANNALS OF ONCOLOGY, 2021, 32 : S41 - S41